Perseus Proteomics Inc. (TYO:4882)
Japan flag Japan · Delayed Price · Currency is JPY
143.00
+1.00 (0.70%)
Jul 30, 2026, 3:30 PM JST

Perseus Proteomics Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-716-902-1,102-785-597
Depreciation & Amortization
-2352
Loss (Gain) From Sale of Assets
377215395117
Other Operating Activities
50-1-1--
Change in Accounts Receivable
4-8-3--1
Change in Inventory
-1--1--1
Change in Accounts Payable
-34812210
Change in Other Net Operating Assets
711011799-6
Operating Cash Flow
-653-719-833-564-476
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-9-75-143-164-33
Sale (Purchase) of Intangibles
---15-6-
Other Investing Activities
-1-8-42-
Investing Cash Flow
-10-75-150-212-33

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Issuance of Common Stock
50392763-2,652
Other Financing Activities
-6-4---5
Financing Cash Flow
49792363-2,647

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
13-21678
Miscellaneous Cash Flow Adjustments
1-11--1
Net Cash Flow
-152126-903-7692,145

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-662-794-976-728-509
Free Cash Flow Growth
-----
Free Cash Flow Margin
-490.37%-661.67%-976.00%-774.47%-716.90%
Free Cash Flow Per Share
-44.41-55.65-82.80-61.91-46.29
Levered Free Cash Flow
-518.63-592.25-736.38-631.63-249.63
Unlevered Free Cash Flow
-518.63-592.25-736.38-631.63-249.63

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Income Tax Paid
21111
Change in Working Capital
-241101141212